Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 202 entries
Sorted by: Best Match Show Resources per page
Review of article: Vascular complications in biliary atresia patients undergoing living donor liver transplantation: Analysis of 110 patients over 10 years.

Journal of Indian Association of Pediatric Surgeons

D'Cruz A.
PMID: 26166982
J Indian Assoc Pediatr Surg. 2015 Jul-Sep;20(3):127. doi: 10.4103/0971-9261.159018.

No abstract available.

Cite
D'Cruz A. Review of article: Vascular complications in biliary atresia patients undergoing living donor liver transplantation: Analysis of 110 patients over 10 years. J Indian Assoc Pediatr Surg. 2015;20(3):127doi: 10.4103/0971-9261.159018.
D'Cruz, A. (2015). Review of article: Vascular complications in biliary atresia patients undergoing living donor liver transplantation: Analysis of 110 patients over 10 years. Journal of Indian Association of Pediatric Surgeons, 20(3), 127. https://doi.org/10.4103/0971-9261.159018
D'Cruz, Ashley. "Review of article: Vascular complications in biliary atresia patients undergoing living donor liver transplantation: Analysis of 110 patients over 10 years." Journal of Indian Association of Pediatric Surgeons vol. 20,3 (2015): 127. doi: https://doi.org/10.4103/0971-9261.159018
D'Cruz A. Review of article: Vascular complications in biliary atresia patients undergoing living donor liver transplantation: Analysis of 110 patients over 10 years. J Indian Assoc Pediatr Surg. 2015 Jul-Sep;20(3):127. doi: 10.4103/0971-9261.159018. PMID: 26166982; PMCID: PMC4481623.
Copy Download .nbib Format: NLM
Risk Management for General Dental Practitioners Providing Orthodontic Treatment.

Primary dental journal

Williams A, D'Cruz L.
PMID: 28107134
Prim Dent J. 2016 Nov 01;5(4):50-55. doi: 10.1308/205016816820209424.

No abstract available.

Cite
Williams A, D'Cruz L. Risk Management for General Dental Practitioners Providing Orthodontic Treatment. Prim Dent J. 2016;5(4):50-55doi: 10.1308/205016816820209424.
Williams, A., & D'Cruz, L. (2016). Risk Management for General Dental Practitioners Providing Orthodontic Treatment. Primary dental journal, 5(4), 50-55. https://doi.org/10.1308/205016816820209424
Williams, Alison, and D'Cruz, Len. "Risk Management for General Dental Practitioners Providing Orthodontic Treatment." Primary dental journal vol. 5,4 (2016): 50-55. doi: https://doi.org/10.1308/205016816820209424
Williams A, D'Cruz L. Risk Management for General Dental Practitioners Providing Orthodontic Treatment. Prim Dent J. 2016 Nov 01;5(4):50-55. doi: 10.1308/205016816820209424. PMID: 28107134.
Copy Download .nbib Format: NLM
Intraoperative Tracheoesophageal Partywall Thickness (PWT) Measurement in Laryngectomy Patients Using Modified PROVOX Guidewire.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Sayed S, Chaukar D, Chaturvedi P, Pai P, Pantvaidya G, Deshmukh A, Nair D, D'cruz A.
PMID: 24381925
Indian J Otolaryngol Head Neck Surg. 2013 Jan;65(1):71-5. doi: 10.1007/s12070-012-0607-5. Epub 2012 Dec 08.

Post laryngectomy voice rehabilitation using primary tracheoesophageal puncture (TEP) and voice prosthesis insertion is considered the "gold standard" method. No special effort is taken to measure the tracheoesophageal partywall thickness before inserting voice prosthesis. TE puncture related problems (peri-prosthetic...

Cite
Sayed S, Chaukar D, Chaturvedi P, et al. Intraoperative Tracheoesophageal Partywall Thickness (PWT) Measurement in Laryngectomy Patients Using Modified PROVOX Guidewire. Indian J Otolaryngol Head Neck Surg. 2012;65(1):71-5doi: 10.1007/s12070-012-0607-5.
Sayed, S., Chaukar, D., Chaturvedi, P., Pai, P., Pantvaidya, G., Deshmukh, A., Nair, D., & D'cruz, A. (2013). Intraoperative Tracheoesophageal Partywall Thickness (PWT) Measurement in Laryngectomy Patients Using Modified PROVOX Guidewire. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 65(1), 71-5. https://doi.org/10.1007/s12070-012-0607-5
Sayed, Suhail, et al. "Intraoperative Tracheoesophageal Partywall Thickness (PWT) Measurement in Laryngectomy Patients Using Modified PROVOX Guidewire." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 65,1 (2013): 71-5. doi: https://doi.org/10.1007/s12070-012-0607-5
Sayed S, Chaukar D, Chaturvedi P, Pai P, Pantvaidya G, Deshmukh A, Nair D, D'cruz A. Intraoperative Tracheoesophageal Partywall Thickness (PWT) Measurement in Laryngectomy Patients Using Modified PROVOX Guidewire. Indian J Otolaryngol Head Neck Surg. 2013 Jan;65(1):71-5. doi: 10.1007/s12070-012-0607-5. Epub 2012 Dec 08. PMID: 24381925; PMCID: PMC3585569.
Copy Download .nbib Format: NLM
22 vascular complications in living donor pediatric liver transplant (ldlt).

Journal of clinical and experimental hepatology

Zameer M, Pavitra, Vinay C, Rao S, D'Cruz A, Dayananada.
PMID: 25755351
J Clin Exp Hepatol. 2011 Sep;1(2):143. doi: 10.1016/S0973-6883(11)60159-X.

No abstract available.

Cite
Zameer M, Pavitra, Vinay C, et al. 22 vascular complications in living donor pediatric liver transplant (ldlt). J Clin Exp Hepatol. 2011;1(2):143doi: 10.1016/S0973-6883(11)60159-X.
Zameer, M., Pavitra, Vinay, C., Rao, S., D'Cruz, A., & Dayananada. (2011). 22 vascular complications in living donor pediatric liver transplant (ldlt). Journal of clinical and experimental hepatology, 1(2), 143. https://doi.org/10.1016/S0973-6883(11)60159-X
Zameer, Mm, et al. "22 vascular complications in living donor pediatric liver transplant (ldlt)." Journal of clinical and experimental hepatology vol. 1,2 (2011): 143. doi: https://doi.org/10.1016/S0973-6883(11)60159-X
Zameer M, Pavitra, Vinay C, Rao S, D'Cruz A, Dayananada. 22 vascular complications in living donor pediatric liver transplant (ldlt). J Clin Exp Hepatol. 2011 Sep;1(2):143. doi: 10.1016/S0973-6883(11)60159-X. PMID: 25755351; PMCID: PMC3940175.
Copy Download .nbib Format: NLM
Right Heart Ischemic Involvement TEE-Dobutamine Stress Assessment.

Echocardiography (Mount Kisco, N.Y.)

D'cruz IA.
PMID: 11175027
Echocardiography. 1998 Feb;15(2):169-170. doi: 10.1111/j.1540-8175.1998.tb00594.x.

No abstract available.

Cite
D'cruz IA. Right Heart Ischemic Involvement TEE-Dobutamine Stress Assessment. Echocardiography. 1998;15(2):169-170doi: 10.1111/j.1540-8175.1998.tb00594.x.
D'cruz, I. A. (1998). Right Heart Ischemic Involvement TEE-Dobutamine Stress Assessment. Echocardiography (Mount Kisco, N.Y.), 15(2), 169-170. https://doi.org/10.1111/j.1540-8175.1998.tb00594.x
D'cruz, Ivan A.. "Right Heart Ischemic Involvement TEE-Dobutamine Stress Assessment." Echocardiography (Mount Kisco, N.Y.) vol. 15,2 (1998): 169-170. doi: https://doi.org/10.1111/j.1540-8175.1998.tb00594.x
D'cruz IA. Right Heart Ischemic Involvement TEE-Dobutamine Stress Assessment. Echocardiography. 1998 Feb;15(2):169-170. doi: 10.1111/j.1540-8175.1998.tb00594.x. PMID: 11175027.
Copy Download .nbib Format: NLM
Lymphoepithelioma-like carcinoma of the vulva.

Journal of lower genital tract disease

Niu W, Heller DS, D'Cruz C.
PMID: 17051066
J Low Genit Tract Dis. 2003 Jul;7(3):184-6. doi: 10.1097/00128360-200307000-00005.

Lymphoepithelioma is well known in the nasopharyngeal region. Although this neoplasm is well described in a variety of extranasal sites, where it is termed lymphoepithelioma-like carcinoma, this is only the second report of this neoplasm originating in the vulva...

Cite
Niu W, Heller DS, D'Cruz C. Lymphoepithelioma-like carcinoma of the vulva. J Low Genit Tract Dis. 2003;7(3):184-6doi: 10.1097/00128360-200307000-00005.
Niu, W., Heller, D. S., & D'Cruz, C. (2003). Lymphoepithelioma-like carcinoma of the vulva. Journal of lower genital tract disease, 7(3), 184-6. https://doi.org/10.1097/00128360-200307000-00005
Niu, Weiwei, et al. "Lymphoepithelioma-like carcinoma of the vulva." Journal of lower genital tract disease vol. 7,3 (2003): 184-6. doi: https://doi.org/10.1097/00128360-200307000-00005
Niu W, Heller DS, D'Cruz C. Lymphoepithelioma-like carcinoma of the vulva. J Low Genit Tract Dis. 2003 Jul;7(3):184-6. doi: 10.1097/00128360-200307000-00005. PMID: 17051066.
Copy Download .nbib Format: NLM
Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma.

World journal of surgical oncology

Walvekar RR, Kane SV, D'Cruz AK.
PMID: 16984659
World J Surg Oncol. 2006 Sep 19;4:65. doi: 10.1186/1477-7819-4-65.

BACKGROUND: Collision tumors of the thyroid gland are a rare entity. We present a case of a follicular variant of papillary carcinoma and squamous carcinoma in the thyroid. To the best of our knowledge, this is the first documentation...

Cite
Walvekar RR, Kane SV, D'Cruz AK. Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma. World J Surg Oncol. 2006;4:65doi: 10.1186/1477-7819-4-65.
Walvekar, R. R., Kane, S. V., & D'Cruz, A. K. (2006). Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma. World journal of surgical oncology, 465. https://doi.org/10.1186/1477-7819-4-65
Walvekar, Rohan R, et al. "Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma." World journal of surgical oncology vol. 4 (2006): 65. doi: https://doi.org/10.1186/1477-7819-4-65
Walvekar RR, Kane SV, D'Cruz AK. Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma. World J Surg Oncol. 2006 Sep 19;4:65. doi: 10.1186/1477-7819-4-65. PMID: 16984659; PMCID: PMC1622750.
Copy Download .nbib Format: NLM
Finite de Finetti theorem for infinite-dimensional systems.

Physical review letters

D'Cruz C, Osborne TJ, Schack R.
PMID: 17501401
Phys Rev Lett. 2007 Apr 20;98(16):160406. doi: 10.1103/PhysRevLett.98.160406. Epub 2007 Apr 19.

We formulate and prove a de Finetti representation theorem for finitely exchangeable states of a quantum system consisting of k infinite-dimensional subsystems. The theorem is valid for states that can be written as the partial trace of a pure...

Cite
D'Cruz C, Osborne TJ, Schack R. Finite de Finetti theorem for infinite-dimensional systems. Phys Rev Lett. 2007;98(16):160406doi: 10.1103/PhysRevLett.98.160406.
D'Cruz, C., Osborne, T. J., & Schack, R. (2007). Finite de Finetti theorem for infinite-dimensional systems. Physical review letters, 98(16), 160406. https://doi.org/10.1103/PhysRevLett.98.160406
D'Cruz, Christian, et al. "Finite de Finetti theorem for infinite-dimensional systems." Physical review letters vol. 98,16 (2007): 160406. doi: https://doi.org/10.1103/PhysRevLett.98.160406
D'Cruz C, Osborne TJ, Schack R. Finite de Finetti theorem for infinite-dimensional systems. Phys Rev Lett. 2007 Apr 20;98(16):160406. doi: 10.1103/PhysRevLett.98.160406. Epub 2007 Apr 19. PMID: 17501401.
Copy Download .nbib Format: NLM
Controversies in the antiphospholipid syndrome: can we ever stop warfarin?.

Journal of autoimmune diseases

Fonseca AG, D'Cruz DP.
PMID: 19014462
J Autoimmune Dis. 2008 Nov 11;5:6. doi: 10.1186/1740-2557-5-6.

Patients with antiphospholipid syndrome are at increased risk for recurrent arterial and venous thrombosis and therefore benefit from long term warfarin therapy. The optimal duration of warfarin therapy after a first venous thromboembolic event is however a matter of...

Cite
Fonseca AG, D'Cruz DP. Controversies in the antiphospholipid syndrome: can we ever stop warfarin?. J Autoimmune Dis. 2008;5:6doi: 10.1186/1740-2557-5-6.
Fonseca, A. G., & D'Cruz, D. P. (2008). Controversies in the antiphospholipid syndrome: can we ever stop warfarin?. Journal of autoimmune diseases, 56. https://doi.org/10.1186/1740-2557-5-6
Fonseca, Ana G, and D'Cruz, David P. "Controversies in the antiphospholipid syndrome: can we ever stop warfarin?." Journal of autoimmune diseases vol. 5 (2008): 6. doi: https://doi.org/10.1186/1740-2557-5-6
Fonseca AG, D'Cruz DP. Controversies in the antiphospholipid syndrome: can we ever stop warfarin?. J Autoimmune Dis. 2008 Nov 11;5:6. doi: 10.1186/1740-2557-5-6. PMID: 19014462; PMCID: PMC2632629.
Copy Download .nbib Format: NLM
The Canadian Natural Health Products (NHP) regulations: industry compliance motivations.

Evidence-based complementary and alternative medicine : eCAM

Laeeque H, Boon H, Kachan N, Cohen JC, D'Cruz J.
PMID: 17549245
Evid Based Complement Alternat Med. 2007 Jun;4(2):257-62. doi: 10.1093/ecam/nel090. Epub 2006 Nov 17.

This qualitative study explores corporations' motivations to comply with new natural health products (NHP) Regulations in Canada. Interviews were conducted with representatives from 20 Canadian NHP companies. Findings show that the rationale for compliance differs for large compared to...

Cite
Laeeque H, Boon H, Kachan N, et al. The Canadian Natural Health Products (NHP) regulations: industry compliance motivations. Evid Based Complement Alternat Med. 2006;4(2):257-62doi: 10.1093/ecam/nel090.
Laeeque, H., Boon, H., Kachan, N., Cohen, J. C., & D'Cruz, J. (2007). The Canadian Natural Health Products (NHP) regulations: industry compliance motivations. Evidence-based complementary and alternative medicine : eCAM, 4(2), 257-62. https://doi.org/10.1093/ecam/nel090
Laeeque, Hina, et al. "The Canadian Natural Health Products (NHP) regulations: industry compliance motivations." Evidence-based complementary and alternative medicine : eCAM vol. 4,2 (2007): 257-62. doi: https://doi.org/10.1093/ecam/nel090
Laeeque H, Boon H, Kachan N, Cohen JC, D'Cruz J. The Canadian Natural Health Products (NHP) regulations: industry compliance motivations. Evid Based Complement Alternat Med. 2007 Jun;4(2):257-62. doi: 10.1093/ecam/nel090. Epub 2006 Nov 17. PMID: 17549245; PMCID: PMC1876621.
Copy Download .nbib Format: NLM
Mycophenolate mofetil in the treatment of lupus nephritis.

Biologics : targets & therapy

Yong PF, D'Cruz DP.
PMID: 19707362
Biologics. 2008 Jun;2(2):297-310. doi: 10.2147/btt.s2266.

Lupus nephritis is a complication of systemic lupus erythematosus, which has significant morbidity and mortality. The accepted standard of treatment for severe lupus nephritis is cyclophosphamide for induction of remission. This has significant adverse effects including severe infection and...

Cite
Yong PF, D'Cruz DP. Mycophenolate mofetil in the treatment of lupus nephritis. Biologics. 2008;2(2):297-310doi: 10.2147/btt.s2266.
Yong, P. F., & D'Cruz, D. P. (2008). Mycophenolate mofetil in the treatment of lupus nephritis. Biologics : targets & therapy, 2(2), 297-310. https://doi.org/10.2147/btt.s2266
Yong, Patrick Fk, and D'Cruz, David P. "Mycophenolate mofetil in the treatment of lupus nephritis." Biologics : targets & therapy vol. 2,2 (2008): 297-310. doi: https://doi.org/10.2147/btt.s2266
Yong PF, D'Cruz DP. Mycophenolate mofetil in the treatment of lupus nephritis. Biologics. 2008 Jun;2(2):297-310. doi: 10.2147/btt.s2266. PMID: 19707362; PMCID: PMC2721349.
Copy Download .nbib Format: NLM
Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis.

Journal of autoimmune diseases

Mialdea M, Sangle SR, D'Cruz DP.
PMID: 19454015
J Autoimmune Dis. 2009 May 19;6:3. doi: 10.1186/1740-2557-6-3.

The antiphospholipid syndrome is an autoimmune disease characterised by recurrent arterial or venous thrombosis, pregnancy morbidity and the persistence of positive antiphospholipid antibodies. Many other clinical manifestations may occur including heart valve disease, livedo reticularis, thrombocytopenia and neurological manifestations...

Cite
Mialdea M, Sangle SR, D'Cruz DP. Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. J Autoimmune Dis. 2009;6:3doi: 10.1186/1740-2557-6-3.
Mialdea, M., Sangle, S. R., & D'Cruz, D. P. (2009). Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. Journal of autoimmune diseases, 63. https://doi.org/10.1186/1740-2557-6-3
Mialdea, Maria, et al. "Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis." Journal of autoimmune diseases vol. 6 (2009): 3. doi: https://doi.org/10.1186/1740-2557-6-3
Mialdea M, Sangle SR, D'Cruz DP. Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. J Autoimmune Dis. 2009 May 19;6:3. doi: 10.1186/1740-2557-6-3. PMID: 19454015; PMCID: PMC2689867.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 202 entries